Skip to Main Content

NK

Animal-origin-free proteins for every step of NK manufacturing.

From starting material to cryopreservation, recombinant albumin, transferrin, IL-2 and insulin-transferrin supplements replace serum and plasma-derived proteins, lowering variability on sensitive NK cells.

Where InVitria proteins fit in NK Manufacturing

NK cell manufacturing leans on proteins at every stage: albumin to protect sensitive cells through collection, selection, washing and freezing, IL-2 to drive activation and expansion, and transferrin to carry iron to dividing cells. Human serum, fetal bovine serum, plasma-derived albumin and transferrin, and bovine albumin supply them with undefined composition and lot-to-lot variability. Defined, animal-origin-free recombinant proteins supply the same functions step by step, and keep human- and animal-derived material out of the final product.

Where our products fit

The NK workflow, step by step.

Eight workflow steps in manufacturing order. Select any step to see the recommended products grouped by function, and why each one is used.

Starting Material

Protect NK cell starting material during collection, handling, and transport with defined, animal-origin-free albumin, supporting recovery and downstream consistency.

Overview

Starting material quality is one of the first variables that can affect NK cell therapy manufacturing performance. NK cell workflows may begin with peripheral blood, donor-derived immune cells, cord blood, iPSC-derived cells, or other NK cell source materials depending on the therapy platform.

Because NK cells are sensitive immune cells, early collection, handling, transport, and hold conditions can affect recovery, viability, activation potential, cytotoxic function, and downstream manufacturing consistency. Variability in donor material, processing time, surface adsorption, and mechanical stress can all influence how well cells perform later in the workflow.

A controlled starting material strategy helps protect the cell population before activation, expansion, engineering, or final processing. Stabilizing cells during early handling can support stronger recovery, lower variability, and a more consistent foundation for NK cell therapy manufacturing.

Functions

Starting Material Stabilization

NK cells are sensitive immune cells, and early collection, handling, transport, and hold conditions affect recovery, viability, and cytotoxic potential. Whatever the source, the starting material is exposed to mechanical stress, surface adsorption, and processing delays before manufacturing begins. A stabilizing protein in the material helps protect the cell population through this early window, before isolation and culture.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Plasma-derived (HSA) serum albumin used to stabilize cellular starting material.

NK Cell Isolation & Enrichment

Deplete CD3+ T cells and enrich CD56+ NK cells, with defined, animal-origin-free albumin supporting cell health through selection.

Overview

Isolation and enrichment recovers NK cells from the starting material. For peripheral blood and cord blood, the product is first washed to remove plasma, platelets, and debris and to reduce volume. NK cells are then isolated, typically by depleting CD3+ T cells, which lowers the risk of graft-versus-host disease in the allogeneic setting, followed by enrichment of CD56+ NK cells. iPSC-derived and cell-line NK products arrive without this depletion step.

Selection and wash buffers are typically PBS with EDTA, supplemented with albumin. The albumin is supplied by the processing site, not built into the buffer. It supports cells through magnetic labeling and column separation, limiting cell loss and protecting viability during handling.

A defined, animal-origin-free recombinant albumin, used in place of human serum albumin, keeps this step consistent and free of human- and animal-derived material before activation and culture begin.

Functions

Cell Protection & Stabilization

During wash and magnetic selection, cells undergo buffer exchange, bead labeling, and column passage. This handling can stress cells and cause loss to tubing, column, and container surfaces. A protein in the buffer buffers cells against that stress and limits adsorption, supporting recovery and viability before the cells move into activation and culture.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Human serum albumin (HSA) supplemented into selection and wash buffers.

NK Cell Activation

Activate isolated NK cells and support their entry into proliferation with defined, animal-origin-free components ahead of expansion.

Overview

NK cell activation prepares isolated NK cells for expansion and effector function. Cells are stimulated with cytokines, most commonly IL-2 and IL-15, sometimes with IL-12, IL-18, or IL-21, over a short activation window. Activation and expansion are often performed together rather than as separate steps.

As cells activate, demand rises across several needs at once: cytokine signaling to support survival and proliferation, iron to fuel metabolism, carrier protein to buffer handling stress and stabilize cytokines, and metabolic support. These are usually met in a defined culture medium.

Meeting these needs with defined, animal-origin-free components, rather than serum, supports consistent activation and reduces variability before expansion scales the population up.

Functions

Cytokine Signaling

NK cells depend on cytokine signaling to survive, activate, and proliferate. IL-2 and IL-15 are the primary cytokines used; IL-15 in particular drives NK survival and proliferation, while IL-2 is widely used in clinical protocols. Consistent cytokine input during activation supports a uniform starting point before expansion.

Recommendation
OptiLeukin™ 2

Recombinant human interleukin-2 from a non-bacterial expression system for T-cell, Treg, TIL, NK, and γδ T-cell expansion, from research to cGMP manufacturing.

Commonly replaces
Mammalian-cell-derived IL-2; E. coli-derived recombinant IL-2 products.

Iron Transport

Activation drives NK cells into the cell cycle, and iron demand rises to support metabolism and proliferation. The transferrin receptor is upregulated on activated, dividing cells, so iron delivery becomes relevant at this step. Transferrin binds ferric iron and delivers it through that receptor in a controlled, protein-bound form, rather than as free iron, which can add oxidative stress.

Recommendation
Optiferrin®

Recombinant human transferrin, lyophilized, for iron delivery in serum-free and chemically defined media.

Commonly replaces
Plasma- or blood-derived transferrin, and free iron supplementation.

Carrier & Protection

During activation and early culture, NK cells are exposed to handling, surface contact, and metabolic stress. Albumin is the primary protein that transports fatty acids and metal ions, contributes antioxidant capacity, buffers cells against shear and surface adsorption, and helps stabilize cytokines in culture, supporting viability through the activation window.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Plasma-derived (HSA) or bovine (BSA) serum albumin, and serum used as a stabilizing protein.

Activation Environment Support

Activating NK cells need iron, metabolic cofactors, and carrier protein together to move cleanly into proliferation in a defined medium. Meeting these needs through defined components, rather than serum, supports consistent activation and reduces the lot-to-lot variability serum introduces during a step that sets the starting point for expansion.

Recommendation
ITSE+A Animal-Free®

Five-component 100x supplement of recombinant insulin, recombinant human transferrin, selenium, ethanolamine, and recombinant human albumin for serum-free cell culture.

Commonly replaces
Human AB serum, fetal bovine serum, and other undefined serum supplementation.

Genetic Modification

Where NK cells are engineered, protect cell health with defined, animal-origin-free conditions through a transduction step that stresses NK cells.

Overview

Genetic modification is an optional step used to produce CAR-NK cells. Many NK therapies are non-engineered, relying on the natural cytotoxicity of expanded NK cells. When engineering is performed, a chimeric antigen receptor (CAR) is introduced, most often by viral transduction, though electroporation and other non-viral methods are increasingly used.

NK cells are notably harder to engineer than T cells. They are prone to apoptosis following viral exposure and have lower transduction efficiency, which makes cell protection during gene transfer especially important. Handling, viral exposure, and media changes all stress the cells during this step.

A controlled, animal-origin-free strategy helps protect cell health, support gene delivery, and maintain consistent conditions through one of the most sensitive steps in CAR-NK manufacturing.

Functions

Cell Protection & Stabilization

Where NK cells are engineered, gene transfer exposes them to viral particles, media changes, and handling. NK cells are especially prone to apoptosis after viral exposure, so stabilizing the culture environment is important to preserve viable cells. Albumin is the primary protein that buffers cells against shear, limits oxidative stress, and reduces adsorption of cells and proteins to surfaces.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Plasma-derived (HSA) or bovine (BSA) serum albumin, and serum used as a stabilizing protein.

Iron Transport

Engineered NK cells require iron for metabolism and to stay proliferation-ready through gene transfer. Transferrin binds ferric iron and delivers it through the transferrin receptor in a controlled, protein-bound form, rather than as free iron, which can contribute to oxidative stress during a sensitive step.

Recommendation
Optiferrin®

Recombinant human transferrin, lyophilized, for iron delivery in serum-free and chemically defined media.

Commonly replaces
Plasma- or blood-derived transferrin, and free iron supplementation.

Pre & Post Transduction Environment Support

During transduction, NK cells must stay viable and stable while exposed to viral particles, media changes, and handling, then recover before expansion continues. They need carrier proteins to buffer stress, iron to maintain metabolism, and cofactors for oxidative balance. Meeting these needs through defined components, rather than serum, supports cell health and consistent conditions across runs.

Recommendation
ITSE+A Animal-Free®

Five-component 100x supplement of recombinant insulin, recombinant human transferrin, selenium, ethanolamine, and recombinant human albumin for serum-free cell culture.

Commonly replaces
FBS, human serum, or undefined serum supplementation

NK Cell Expansion

Maintain NK cell proliferation, viability, and cytotoxic function while reducing undefined and animal-origin components in expansion media.

Overview

Cell expansion increases the number of NK cells to reach the target therapeutic dose. NK cells are present at low frequency in blood, so robust expansion is essential. Cells must proliferate efficiently while maintaining viability and cytotoxic function.

Expansion is driven by cytokines such as IL-2 and IL-15, and often by co-culture with irradiated feeder cells engineered to present stimulatory signals. Outcomes depend on cytokine stability, media composition, and process conditions. Undefined or animal-origin components can introduce lot-to-lot variability.

A defined, animal-origin-free expansion strategy supports scalable manufacturing, consistent cell growth, and greater confidence in final product quality.

Clinical NK expansion typically uses engineered feeder cells (e.g., K562 expressing membrane-bound IL-21/IL-15 and 41BBL) with IL-2 and/or IL-15 to drive large-scale, functional expansion.

Functions

Cytokine Signaling

Cytokine signaling sustains proliferation and survival of NK cells during expansion. IL-2 and IL-15 are the primary signals driving expansion to the target dose, often alongside feeder cells that present stimulatory cytokines and ligands.

Recommendation
OptiLeukin™ 2

Recombinant human interleukin-2 from a non-bacterial expression system for T-cell, Treg, TIL, NK, and γδ T-cell expansion, from research to cGMP manufacturing.

Commonly replaces
Mammalian-cell-derived IL-2; E. coli-derived recombinant IL-2 products

Iron Transport

Proliferating NK cells require iron for DNA synthesis and metabolic activity during expansion. Transferrin is the physiological carrier that binds ferric iron and delivers it through the transferrin receptor, which is upregulated on actively dividing cells. A defined iron-delivery mechanism supports consistent proliferation and viability and avoids the variability of undefined iron sources.

Recommendation
Optiferrin®

Recombinant human transferrin, lyophilized, for iron delivery in serum-free and chemically defined media.

Commonly replaces
Human plasma- or blood-derived transferrin, and serum used as an iron source.

Carrier & Protection

Albumin is the primary protein carrier in culture. It binds and transports fatty acids, lipids, and metal ions, contributes antioxidant capacity, and buffers cells against shear and handling stress. During NK expansion in cytokine-rich, defined media, this carrier and protective role supports viability, helps stabilize cytokines, and promotes consistent growth.

Recommendation
Optibumin® 20

High-purity recombinant human serum albumin excipient, a 20% w/v liquid for cell processing, cryopreservation, and final formulation.

Cellastim® S

Cell culture recombinant albumin to enhance proliferation in serum free and chemically defined cell culture. Lyophilized.

Commonly replaces
Human plasma-derived serum albumin (HSA) and bovine serum albumin (BSA)

Expansion Environment Support

Expanding NK cells depend on a stable culture environment to proliferate consistently while maintaining viability and cytotoxic function. They need carrier proteins to transport lipids and buffer stress, iron for metabolism and DNA synthesis, and metabolic cofactors that support nutrient utilization and oxidative balance. Meeting these needs through defined components, rather than serum, supports consistent growth and reduces variability across runs.

Recommendation
ITSE+A Animal-Free®

Five-component 100x supplement of recombinant insulin, recombinant human transferrin, selenium, ethanolamine, and recombinant human albumin for serum-free cell culture.

Commonly replaces
FBS, human serum, or undefined serum supplementation

Harvest & Concentration

Wash and concentrate the NK cells for formulation, with defined, animal-origin-free albumin protecting them through processing.

Overview

Harvest and concentration prepares the expanded cells for final formulation. The NK cells are collected from culture, washed to remove spent media and process residuals, and concentrated through volume reduction, usually by counterflow centrifugation or filtration. The goal is a clean, concentrated cell suspension ready for fill.

Wash and concentration buffers are saline or PBS supplemented with albumin. The albumin protects cells against the shear of centrifugation or filtration and limits loss to surfaces during processing. Because the cells are washed into this buffer as they approach fill, residual process proteins matter here: bovine albumin, a common additive, is a tracked impurity in the final product.

A defined, animal-origin-free recombinant albumin protects cells through concentration while avoiding the animal-derived residuals that carry toward the drug product.

Functions

Cell Protection & Stabilization

During harvest and concentration, cells are washed and volume-reduced by counterflow centrifugation or filtration, which subjects them to shear and surface contact. Albumin in the buffer buffers cells against that mechanical stress, limits adhesion and loss to surfaces, and supports viability and recovery as the product is concentrated for formulation.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Human serum albumin (HSA) or bovine serum albumin (BSA) supplemented into wash and concentration buffers.

Final Formulation & Fill Prep

Formulate the NK cells into their final matrix with defined, animal-origin-free recombinant albumin, a drug-product excipient that stabilizes the product for fill and storage.

Overview

Final formulation and fill prep brings the product to its finished form. The concentrated cells are suspended in the matrix they will be stored and administered in, then filled into the primary container, a cryobag or vial. A common formulation is an electrolyte solution such as Plasma-Lyte A with a cryoprotectant and albumin.

Albumin is a standard excipient in these matrices. It stabilizes the cells and protects them through formulation and into freezing. Because this is the drug product, excipient safety matters: plasma-derived albumin carries adventitious-agent risk that a recombinant source removes.

A defined, animal-origin-free recombinant albumin stabilizes the formulated product while keeping the final matrix free of human- and animal-derived material as it goes to fill.

Functions

Formulation Stabilization

In final formulation, the concentrated cells are suspended in the matrix they will be stored and administered in, commonly an electrolyte solution with a cryoprotectant. Albumin is a standard excipient in this matrix. It stabilizes cells, buffers them against the osmotic and handling stress of formulation and the hold before freezing, and limits adsorption to the container. As a drug-product excipient, its quality and safety profile carry into the final product.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Plasma-derived human serum albumin (HSA) used as a formulation excipient.

Cryopreservation

Freeze and store the NK cell product, with defined, animal-origin-free albumin supporting stability and post-thaw recovery of cryosensitive NK cells.

Overview

Cryopreservation freezes and stores the finished product. The formulated cells are cooled in a controlled-rate freezer and held in cryogenic storage, typically below -120°C in the vapor phase of liquid nitrogen, then thawed at the point of care before infusion. Freezing decouples manufacturing from the treatment schedule and allows shipment and storage of doses.

Freeze-thaw exposes cells to ice formation and osmotic stress. NK cells are known to be sensitive to cryopreservation and can lose cytotoxic function after thaw, so protecting them through the freeze-thaw cycle matters. Cryopreservation matrices pair a penetrating cryoprotectant such as DMSO with a protein stabilizer. Albumin is that stabilizer: it buffers cell membranes through freezing and supports viability and recovery on thaw.

A defined, animal-origin-free recombinant albumin supports cryostability while keeping the frozen drug product free of human- and animal-derived material.

Functions

Freeze-Thaw Stabilization

Cryopreservation exposes cells to ice crystal formation, osmotic shifts, and membrane stress. NK cells are particularly sensitive to freeze-thaw and can lose cytotoxic function after thaw, so protecting them is important. Cryopreservation matrices pair a penetrating cryoprotectant such as DMSO with a protein stabilizer. Albumin acts as that stabilizer, buffering membranes against osmotic and oxidative stress and supporting viability and recovery after thaw.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Plasma-derived human serum albumin (HSA) used as a cryopreservation stabilizer.